Status:

COMPLETED

Temperature Control During Dialysis Treatment

Lead Sponsor:

Regional Hospital Holstebro

Conditions:

Renal Failure, Chronic

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

The purpose is to measure the effect of glucose in the dialysis water on blood pressure, pulse rate, and plasma glucose with and without body temperature control

Detailed Description

To clarify the influence of temperature in dialysis water on blood pressure and vasoactive hormones

Eligibility Criteria

Inclusion

  • Age \> 18 years,
  • both men and women,
  • chronic renal failure and dialysis treatment for at least three months

Exclusion

  • Heart failure,
  • Lung insufficiency,
  • Chronic liver disease,
  • Diabetes mellitus,
  • Malignant disease,
  • Nephrotic syndrome,
  • Lack of compliance,
  • Unwillingness til participate

Key Trial Info

Start Date :

August 1 2006

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2007

Estimated Enrollment :

18 Patients enrolled

Trial Details

Trial ID

NCT00438295

Start Date

August 1 2006

End Date

May 1 2007

Last Update

September 15 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Holstebro Hospital

Holstebro, Denmark, 7500